DK3786160T3 - Pyridinderivater og terapeutiske anvendelser deraf som trpc6-inhibitorer - Google Patents
Pyridinderivater og terapeutiske anvendelser deraf som trpc6-inhibitorer Download PDFInfo
- Publication number
- DK3786160T3 DK3786160T3 DK20197194.2T DK20197194T DK3786160T3 DK 3786160 T3 DK3786160 T3 DK 3786160T3 DK 20197194 T DK20197194 T DK 20197194T DK 3786160 T3 DK3786160 T3 DK 3786160T3
- Authority
- DK
- Denmark
- Prior art keywords
- therapeutic uses
- pyridine derivatives
- trpc6
- inhibitors
- trpc6 inhibitors
- Prior art date
Links
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical class C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 title 1
- 102000003623 TRPC6 Human genes 0.000 title 1
- 108050001421 Transient receptor potential channel, canonical 6 Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762577883P | 2017-10-27 | 2017-10-27 | |
US201862628313P | 2018-02-09 | 2018-02-09 | |
EP18800513.6A EP3700902B8 (en) | 2017-10-27 | 2018-10-25 | Pyridine carbonyl derivatives and therapeutic uses thereof as trpc6 inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3786160T3 true DK3786160T3 (da) | 2022-08-22 |
Family
ID=64270818
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK20197194.2T DK3786160T3 (da) | 2017-10-27 | 2018-10-25 | Pyridinderivater og terapeutiske anvendelser deraf som trpc6-inhibitorer |
DK18800513.6T DK3700902T3 (en) | 2017-10-27 | 2018-10-25 | Inhibitorer af trpc6 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK18800513.6T DK3700902T3 (en) | 2017-10-27 | 2018-10-25 | Inhibitorer af trpc6 |
Country Status (29)
Country | Link |
---|---|
US (4) | US10889568B2 (da) |
EP (2) | EP3700902B8 (da) |
JP (2) | JP7217273B6 (da) |
KR (2) | KR20200125758A (da) |
CN (1) | CN111527078B (da) |
AU (2) | AU2018355743B2 (da) |
BR (1) | BR112020007818A2 (da) |
CA (1) | CA3078769A1 (da) |
CL (2) | CL2020001097A1 (da) |
CY (1) | CY1126109T1 (da) |
DK (2) | DK3786160T3 (da) |
ES (2) | ES2946274T3 (da) |
FI (1) | FI3700902T3 (da) |
HR (2) | HRP20220991T1 (da) |
HU (2) | HUE062460T2 (da) |
IL (2) | IL274039B (da) |
LT (2) | LT3786160T (da) |
MX (1) | MX2020004283A (da) |
PE (1) | PE20210154A1 (da) |
PH (1) | PH12020550503A1 (da) |
PL (2) | PL3786160T3 (da) |
PT (2) | PT3700902T (da) |
RS (2) | RS64271B1 (da) |
SA (1) | SA520411843B1 (da) |
SG (2) | SG11202003367TA (da) |
SI (2) | SI3786160T1 (da) |
TW (2) | TWI780511B (da) |
WO (1) | WO2019081637A1 (da) |
ZA (1) | ZA202002372B (da) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10889568B2 (en) * | 2017-10-27 | 2021-01-12 | Boehringer Ingelheim International Gmbh | Inhibitors of TRPC6 |
EP3752499B1 (en) * | 2018-02-15 | 2024-03-27 | Boehringer Ingelheim International GmbH | Inhibitors of trpc6 |
US11370771B2 (en) * | 2018-02-16 | 2022-06-28 | Boehringer Ingelheim International Gmbh | Inhibitors of TRPC6 |
MA53431A (fr) * | 2018-08-24 | 2021-06-30 | Xeniopro GmbH | Nouvelles molécules aromatiques |
JP2022527618A (ja) * | 2019-04-12 | 2022-06-02 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Trpc6阻害剤 |
WO2021079962A1 (ja) * | 2019-10-24 | 2021-04-29 | 国立大学法人大阪大学 | 難聴の予防および/または治療用医薬組成物 |
WO2021160625A1 (en) | 2020-02-11 | 2021-08-19 | Klinikum Rechts Der Isar | Administration of calcium channel trpc6 inhibitors using balloons, stents or other medical devices |
AR121846A1 (es) * | 2020-04-16 | 2022-07-13 | Teijin Pharma Ltd | Derivado de arilo o heteroarilo |
MX2022012923A (es) | 2020-04-16 | 2022-11-16 | Boehringer Ingelheim Int | Inhibidores de trpc6 para tratar afecciones respiratorias. |
CN113105318B (zh) * | 2021-02-23 | 2022-05-20 | 中山大学 | 一种2,2-二氟环丁烷-1-羧酸的制备方法及应用 |
CN118055765A (zh) | 2021-10-15 | 2024-05-17 | 勃林格殷格翰国际有限公司 | 用于治疗脓毒症的trpc6抑制性化合物 |
WO2023106421A1 (ja) * | 2021-12-06 | 2023-06-15 | 国立大学法人熊本大学 | Trpc6の発現を抑制する方法 |
Family Cites Families (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0507863A4 (en) | 1989-12-28 | 1993-07-07 | Virginia Commonwealth University | Sigma receptor ligands and the use thereof |
CA2111957A1 (en) | 1991-06-27 | 1993-01-07 | Richard A. Glennon | Sigma receptor ligands and the use thereof |
BR9307570A (pt) | 1992-12-02 | 1999-05-25 | Pfizer | Diéteres de catecol como inibidores seletivos de pdeiv |
US6673799B1 (en) | 1998-09-22 | 2004-01-06 | Yamanouchi Pharmaceutical Co. Ltd. | Cyanophenyl derivative |
CA2401778C (en) | 2000-02-29 | 2010-12-21 | Cor Therapeutics, Inc. | Benzamides and related inhibitors of factor xa |
EP1301484A2 (en) | 2000-07-20 | 2003-04-16 | Neurogen Corporation | Capsaicin receptor ligands |
CN1300114C (zh) * | 2001-06-15 | 2007-02-14 | 安斯泰来制药有限公司 | 苯基吡啶甲酰哌嗪衍生物 |
JP4186518B2 (ja) * | 2001-06-15 | 2008-11-26 | アステラス製薬株式会社 | フェニルピリジン誘導体 |
NI200300045A (es) | 2002-04-26 | 2005-07-08 | Pfizer Prod Inc | Inhibidores de triariloxiariloxipirimidin-2,4,6-triona de metaloproteinasa. |
DE10222291A1 (de) | 2002-05-18 | 2003-11-27 | Schlafhorst & Co W | Faserbandzuführeinrichtung |
CN1150176C (zh) | 2002-05-22 | 2004-05-19 | 上海医药工业研究院 | 芳烷酮哌嗪衍生物及其应用 |
WO2006044174A2 (en) | 2004-10-13 | 2006-04-27 | Neurogen Corporation | Aryl substituted 8-azabicyclo[3.2.1]octane compounds as ligands of the melanin concentrating hormone receptor |
DE102005044814A1 (de) | 2005-05-19 | 2006-11-23 | Grünenthal GmbH | Substituierte Sprio-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln |
TWI325423B (en) | 2005-10-28 | 2010-06-01 | Lilly Co Eli | Kinase inhibitors |
CN101426777A (zh) | 2005-12-21 | 2009-05-06 | 先灵公司 | 用作组胺h3拮抗剂的苯氧基哌啶及其类似物 |
JP5019768B2 (ja) | 2006-03-23 | 2012-09-05 | 独立行政法人科学技術振興機構 | 新規低分子化合物およびその製造方法 |
DK2137162T3 (da) | 2007-03-15 | 2018-11-26 | Novartis Ag | Organiske forbindelser og disses anvendelser |
JP5082538B2 (ja) | 2007-03-28 | 2012-11-28 | Dic株式会社 | ピペラジン化合物 |
EP2379524A1 (en) | 2008-12-18 | 2011-10-26 | Boehringer Ingelheim International GmbH | Serotonin 5-ht2b receptor inhibitors |
US20100234603A1 (en) | 2009-03-13 | 2010-09-16 | Xin Linghu | Process for Making Substituted Aryl Sulfone Intermediates |
US20110039850A1 (en) | 2009-08-12 | 2011-02-17 | Mhairi Copland | Leukemia Treatment |
US8575168B2 (en) | 2009-10-09 | 2013-11-05 | Irm Llc | Compounds and compositions as modulators of GPR119 activity |
KR20120107962A (ko) | 2009-11-18 | 2012-10-04 | 노파르티스 아게 | 고형 종양 및 다른 악성종양의 치료를 위한 방법 및 조성물 |
WO2011109059A1 (en) | 2010-03-01 | 2011-09-09 | Gtx, Inc. | Compounds for treatment of cancer |
ES2653966T3 (es) | 2010-04-27 | 2018-02-09 | Mitsubishi Tanabe Pharma Corporation | Nuevo derivado de amida y su uso como medicina |
EA201291236A1 (ru) | 2010-05-13 | 2013-11-29 | Эмджен Инк. | Азотные гетероциклические соединения, применимые в качестве ингибиторов pde10 |
WO2012016217A1 (en) | 2010-07-29 | 2012-02-02 | Rigel Pharmaceuticals, Inc. | Ampk-activating heterocyclic compounds and methods for using the same |
WO2012158784A2 (en) | 2011-05-16 | 2012-11-22 | Theodore Mark Kamenecka | Modulators of the nuclear hormone receptor ror |
JP5800786B2 (ja) | 2011-10-26 | 2015-10-28 | 田辺三菱製薬株式会社 | 新規アミド誘導体を有効成分として含有する医薬組成物 |
US9139585B2 (en) | 2011-10-31 | 2015-09-22 | Merck Sharp & Dohme Corp. | Inhibitors of the Renal Outer Medullary Potassium channel |
CN103360343B (zh) | 2012-03-30 | 2017-04-19 | 凯惠药业(上海)有限公司 | 一种哌嗪酰胺类化合物的制备方法 |
WO2014139144A1 (en) | 2013-03-15 | 2014-09-18 | Agios Pharmaceuticals, Inc. | Therapeutic compounds and compositions |
TWI642668B (zh) * | 2013-05-27 | 2018-12-01 | 赫孚孟拉羅股份公司 | 新穎3,4-二氫-2h-異喹啉-1-酮及2,3-二氫異吲哚-1-酮化合物 |
US20150087673A1 (en) | 2013-09-26 | 2015-03-26 | Rigel Pharmaceuticals, Inc. | Methods for using and biomarkers for ampk-activating compounds |
WO2015101957A2 (en) | 2014-01-06 | 2015-07-09 | Rhizen Pharmaceuticals Sa | Novel glutaminase inhibitors |
WO2015199206A1 (ja) | 2014-06-27 | 2015-12-30 | 塩野義製薬株式会社 | Trpv4阻害活性を有する6員環誘導体 |
AR102537A1 (es) | 2014-11-05 | 2017-03-08 | Flexus Biosciences Inc | Agentes inmunomoduladores |
MA41598A (fr) | 2015-02-25 | 2018-01-02 | Constellation Pharmaceuticals Inc | Composés thérapeutiques de pyridazine et leurs utilisations |
CA3001857A1 (en) | 2015-10-14 | 2017-04-20 | Aquinnah Pharmaceuticals, Inc. | Compounds, compositions and methods of use against stress granules |
CN107176927B (zh) | 2016-03-12 | 2020-02-18 | 福建金乐医药科技有限公司 | 组蛋白去甲基化酶lsd1抑制剂 |
MD3429591T2 (ro) | 2016-03-16 | 2023-08-31 | Kura Oncology Inc | Derivați de tieno[2,3-d]pirimidină substituiți în calitate de inhibitori ai menin-MLL și procedee de utilizare |
BR112018076564A2 (pt) | 2016-06-20 | 2019-04-02 | Rutgers, The State University Of New Jersey | uso de um composto de fórmula i, composições farmacêuticas, composto de fórmula i, usos de um composto ou um sal farmaceuticamente aceitável do mesmo, e compostos ou sais farmaceuticamente aceitáveis dos mesmos |
CN107540636A (zh) | 2016-06-29 | 2018-01-05 | 成都贝斯凯瑞生物科技有限公司 | 一种含氮杂环衍生物及其应用 |
CN106317050B (zh) * | 2016-08-24 | 2018-11-23 | 烟台大学 | 一种苯基噻唑衍生物及其制备方法与应用 |
JPWO2018159827A1 (ja) | 2017-03-03 | 2020-01-09 | 国立大学法人京都大学 | 植物ステロイドホルモン(ブラシノライド)様活性をもつ非ステロイド化合物の創製 |
US10450303B2 (en) | 2017-03-15 | 2019-10-22 | Athenex, Inc. | Biaryl piperidine amide compounds and methods of use thereof |
US10889568B2 (en) | 2017-10-27 | 2021-01-12 | Boehringer Ingelheim International Gmbh | Inhibitors of TRPC6 |
MA50906A (fr) * | 2017-11-16 | 2020-09-23 | Principia Biopharma Inc | Inhibiteurs d'immunoprotéasome |
EP3752499B1 (en) | 2018-02-15 | 2024-03-27 | Boehringer Ingelheim International GmbH | Inhibitors of trpc6 |
US11370771B2 (en) | 2018-02-16 | 2022-06-28 | Boehringer Ingelheim International Gmbh | Inhibitors of TRPC6 |
-
2018
- 2018-10-25 US US16/170,178 patent/US10889568B2/en active Active
- 2018-10-25 PT PT188005136T patent/PT3700902T/pt unknown
- 2018-10-25 EP EP18800513.6A patent/EP3700902B8/en active Active
- 2018-10-25 TW TW109138850A patent/TWI780511B/zh active
- 2018-10-25 PL PL20197194.2T patent/PL3786160T3/pl unknown
- 2018-10-25 WO PCT/EP2018/079276 patent/WO2019081637A1/en active Application Filing
- 2018-10-25 MX MX2020004283A patent/MX2020004283A/es unknown
- 2018-10-25 PE PE2020000424A patent/PE20210154A1/es unknown
- 2018-10-25 HU HUE18800513A patent/HUE062460T2/hu unknown
- 2018-10-25 EP EP20197194.2A patent/EP3786160B1/en active Active
- 2018-10-25 HR HRP20220991TT patent/HRP20220991T1/hr unknown
- 2018-10-25 PL PL18800513.6T patent/PL3700902T3/pl unknown
- 2018-10-25 TW TW107137733A patent/TWI780246B/zh active
- 2018-10-25 CN CN201880070122.4A patent/CN111527078B/zh active Active
- 2018-10-25 LT LTEP20197194.2T patent/LT3786160T/lt unknown
- 2018-10-25 RS RS20230382A patent/RS64271B1/sr unknown
- 2018-10-25 JP JP2020523445A patent/JP7217273B6/ja active Active
- 2018-10-25 DK DK20197194.2T patent/DK3786160T3/da active
- 2018-10-25 HR HRP20230502TT patent/HRP20230502T1/hr unknown
- 2018-10-25 ES ES18800513T patent/ES2946274T3/es active Active
- 2018-10-25 AU AU2018355743A patent/AU2018355743B2/en active Active
- 2018-10-25 SG SG11202003367TA patent/SG11202003367TA/en unknown
- 2018-10-25 SI SI201830732T patent/SI3786160T1/sl unknown
- 2018-10-25 HU HUE20197194A patent/HUE059450T2/hu unknown
- 2018-10-25 BR BR112020007818-2A patent/BR112020007818A2/pt unknown
- 2018-10-25 KR KR1020207031025A patent/KR20200125758A/ko not_active Application Discontinuation
- 2018-10-25 LT LTEPPCT/EP2018/079276T patent/LT3700902T/lt unknown
- 2018-10-25 DK DK18800513.6T patent/DK3700902T3/da active
- 2018-10-25 SG SG10202011632RA patent/SG10202011632RA/en unknown
- 2018-10-25 ES ES20197194T patent/ES2924933T3/es active Active
- 2018-10-25 SI SI201830924T patent/SI3700902T1/sl unknown
- 2018-10-25 US US16/170,154 patent/US10800757B2/en not_active Ceased
- 2018-10-25 FI FIEP18800513.6T patent/FI3700902T3/fi active
- 2018-10-25 CA CA3078769A patent/CA3078769A1/en active Pending
- 2018-10-25 RS RS20220752A patent/RS63535B1/sr unknown
- 2018-10-25 KR KR1020207014013A patent/KR20200095467A/ko not_active Application Discontinuation
- 2018-10-25 PT PT201971942T patent/PT3786160T/pt unknown
-
2020
- 2020-04-19 IL IL274039A patent/IL274039B/en unknown
- 2020-04-23 CL CL2020001097A patent/CL2020001097A1/es unknown
- 2020-04-26 SA SA520411843A patent/SA520411843B1/ar unknown
- 2020-04-27 PH PH12020550503A patent/PH12020550503A1/en unknown
- 2020-05-04 ZA ZA2020/02372A patent/ZA202002372B/en unknown
- 2020-09-22 IL IL277493A patent/IL277493B/en unknown
- 2020-10-02 CL CL2020002562A patent/CL2020002562A1/es unknown
- 2020-10-06 AU AU2020250185A patent/AU2020250185B2/en active Active
- 2020-10-08 JP JP2020170563A patent/JP6979502B2/ja active Active
- 2020-12-08 US US17/115,667 patent/US20210163449A1/en not_active Abandoned
-
2021
- 2021-05-28 US US17/334,097 patent/USRE49699E1/en active Active
-
2023
- 2023-06-07 CY CY20231100270T patent/CY1126109T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3786160T3 (da) | Pyridinderivater og terapeutiske anvendelser deraf som trpc6-inhibitorer | |
DK3728254T3 (da) | Benzylamin-substituerede pyridopyrimidinoner og derivater som sos1-inhibitorer | |
DK3478693T3 (da) | Boronsyrederivater og terapeutiske anvendelser deraf | |
DK3452463T3 (da) | Amidsubstituerede pyridinyltriazolderivater og anvendelser deraf | |
DK3331894T3 (da) | Nicotinamidmononukleotidderivater og anvendelser deraf | |
DK3277681T3 (da) | Imidazolonylquinoliner og deres anvendelse som atm-kinaseinhibitorer | |
DK3389658T3 (da) | Glycosidasehæmmere og anvendelser deraf | |
DK3328849T3 (da) | 1,1,1-trifluor-3-hydroxypropan-2-yl-carbamat-derivater og 1,1,1-trifluor-4-hydroxybutan-2-yl-carbamat-derivater som magl-inhibitorer | |
DK3149001T3 (da) | Hidtil ukendte pyrazolopyrimidinderivater og deres anvendelse som MALT1-hæmmere | |
DK3250237T3 (da) | Hemiasterlinderivater til konjugering og terapi | |
DK3357513T3 (da) | Farmaceutisk sammensætning og anvendelse deraf | |
DK3532459T3 (da) | Lsd1-hæmmere og medicinske anvendelser deraf | |
DK3514153T3 (da) | Pyrimidinforbindelse og farmaceutisk anvendelse deraf | |
DK3412660T3 (da) | Sulfonamidderivat og farmaceutisk sammensætning indeholdende samme | |
DK3621694T3 (da) | Lrrc33-inhibitorer og anvendelse heraf | |
DK3268374T3 (da) | Kv1.3-inhibitorer og deres medicinske anvendelse | |
DK3971177T3 (da) | Aminopyridin-derivater og anvendelse deraf som selektive ALK-2-inhibitorer | |
DK3797107T3 (da) | Heterokondenserede pyridonforbindelser og anvendelse deraf som idh- hæmmere | |
DK3386956T3 (da) | Fumagillolderivater og polymorfer deraf | |
DK3277682T3 (da) | 6-morpholinyl-2-pyrazolyl-9h-purinderivater og anvendelse heraf som pi3k- hæmmere | |
DK3568396T3 (da) | Hidtil ukendte amino-imidazopyridinderivater som janus kinase-inhibitorer og farmaceutisk anvendelse deraf | |
DK3615502T3 (da) | Terapeutiske forbindelser og fremgangsmåder | |
DK3455216T3 (da) | Pyridinylderivater, farmaceutiske sammensætninger og anvendelser deraf som aoc3-inhibitorer | |
DK3362450T3 (da) | N1- og N7-substituerede sibirilin-derivater og anvendelse deraf som inhibitorer af cellulær nekroptose | |
DK3280405T3 (da) | Inhibitorer og anvendelser deraf |